[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$bsln](/topic/$bsln)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$BSLN #Basilea awarded #BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-leaborbactam. Total non-dilutive funding of up to $159M"  
[X Link](https://x.com/doepke_michel/status/1971084256689713294) [@doepke_michel](/creator/x/doepke_michel) 2025-09-25T05:28Z 5604 followers, 1047 engagements


"SWISS PREMARKET: $SMI +011% $SMIM -XXX% $LOGN +11% (broker call) $SCMN +06% (Weko news) $AMS +06% (broker call) $BSLN +11% (BARDA payment) $SCHP -XX% (share placement) $SDZ +11% (broker call) $UBXN -X% Most other shares marginally higher traded so far"  
[X Link](https://x.com/cashInsider/status/1967831755379109903) [@cashInsider](/creator/x/cashInsider) 2025-09-16T06:03Z 5860 followers, 3173 engagements


"Tisdagens analyser📝 - Vi inleder bevakning av Addtech $ADDTB Indutrade $INDT och Lagercrantz $LGRB: Through thick and thin - Gentoo Media #G2M Q4 first takes: Soft margins driving adj EBITDA miss - Basilea Pharmaceutica $BSLN: FY 2024 takes continued growth - Stendrren $STEF.B Q4 first take: Impressive net letting underpin strong tenant demand - Webrock Ventures $WRV Q4 first take: Shifting strategic priorities Ta del av analysrapporterna hr: Lr dig mer om vrt analysutbud:"  
[X Link](https://x.com/ParetoSecSE/status/1891763510901707106) [@ParetoSecSE](/creator/x/ParetoSecSE) 2025-02-18T08:15Z 6166 followers, 1409 engagements